Johnson Pharmacare Limited has announced the resignation of two directors from its board, both effective January 21, 2026. The pharmaceutical company disclosed these changes in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Director Resignations Overview

The company experienced simultaneous departures from its board leadership on January 21, 2026. Both resignations were attributed to personal and unavoidable reasons, with formal documentation submitted to BSE Limited.

Regulatory Compliance and Confirmations

Johnson Pharmacare Limited confirmed receipt of formal resignation letters from both directors. The company stated that it received confirmation from both Mr. Rajender Parsad and Ms. Parul Agrawal that there were no other material reasons for their resignations beyond those provided in their formal submissions.

The resignations were processed in accordance with the provisions of the Companies Act, 2013, and SEBI (LODR) Regulations. Additional Director Umesh Kumar (DIN: 07015921) signed the disclosure documents on behalf of the Board of Directors.

Directors' Other Commitments

Both resigning directors maintain positions with other listed entities. The disclosure revealed their external directorship commitments:

Company Information

Johnson Pharmacare Limited operates with its registered office located at Office No. 4-D, Fourth Floor Vardan Tower, Lakhudi Circle, Near Sardar Patel Stadium, Navrangpura, Ahmedabad, Gujarat. The company's corporate office is situated at 1002 10th Floor, Vikram Tower, Rajendra Place, New Delhi. The company trades on BSE under scrip code 532154 with ISIN INE560F01022.

The formal disclosure documents were submitted to BSE Limited's Department of Corporate Service, ensuring compliance with all regulatory requirements for director changes. Both resignations became effective during working hours on January 21, 2026, marking a significant change in the company's board composition.